1. Home
  2. CGEM vs ARRY Comparison

CGEM vs ARRY Comparison

Compare CGEM & ARRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • ARRY
  • Stock Information
  • Founded
  • CGEM 2016
  • ARRY 1989
  • Country
  • CGEM United States
  • ARRY United States
  • Employees
  • CGEM N/A
  • ARRY N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • ARRY Semiconductors
  • Sector
  • CGEM Health Care
  • ARRY Technology
  • Exchange
  • CGEM Nasdaq
  • ARRY Nasdaq
  • Market Cap
  • CGEM 530.0M
  • ARRY 785.6M
  • IPO Year
  • CGEM 2021
  • ARRY 2020
  • Fundamental
  • Price
  • CGEM $7.68
  • ARRY $7.47
  • Analyst Decision
  • CGEM Strong Buy
  • ARRY Buy
  • Analyst Count
  • CGEM 6
  • ARRY 20
  • Target Price
  • CGEM $28.17
  • ARRY $9.47
  • AVG Volume (30 Days)
  • CGEM 350.6K
  • ARRY 10.9M
  • Earning Date
  • CGEM 08-07-2025
  • ARRY 08-07-2025
  • Dividend Yield
  • CGEM N/A
  • ARRY N/A
  • EPS Growth
  • CGEM N/A
  • ARRY N/A
  • EPS
  • CGEM N/A
  • ARRY N/A
  • Revenue
  • CGEM N/A
  • ARRY $1,064,767,000.00
  • Revenue This Year
  • CGEM N/A
  • ARRY $24.15
  • Revenue Next Year
  • CGEM N/A
  • ARRY $13.19
  • P/E Ratio
  • CGEM N/A
  • ARRY N/A
  • Revenue Growth
  • CGEM N/A
  • ARRY N/A
  • 52 Week Low
  • CGEM $6.85
  • ARRY $3.76
  • 52 Week High
  • CGEM $21.01
  • ARRY $12.06
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 45.96
  • ARRY 54.13
  • Support Level
  • CGEM $7.29
  • ARRY $7.22
  • Resistance Level
  • CGEM $7.94
  • ARRY $7.92
  • Average True Range (ATR)
  • CGEM 0.39
  • ARRY 0.50
  • MACD
  • CGEM -0.01
  • ARRY 0.06
  • Stochastic Oscillator
  • CGEM 61.01
  • ARRY 77.49

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About ARRY Array Technologies Inc.

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.

Share on Social Networks: